Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Gow

Showing results (31-40 of 85) with videos related to

Pageof 9
Sort By:
Journal of Gastroenterology and Hepatology|June 16, 2010
Efficacy and cost of a hepatocellular carcinoma screening program at an Australian teaching hospitalMary Y Y Qian, Rong Yuwei J, Peter Angus, et al.
World Journal of Hepatology|May 1, 2025
Rifaximin-α use is associated with improved muscle mass in patients with cirrhosisThomas Worland, Penelope Hey, Darren Wong, et al.
World Journal of Transplantation|August 18, 2022
Reduced upper limb lean mass on dual energy X-ray absorptiometry predicts adverse outcomes in male liver transplant recipientsPenelope Hey, Rudolf Hoermann, Paul Gow, et al.
Hepatology (Baltimore, Md.)|March 25, 2025
Reply: Targeted enteral feeding for malnutrition in liver transplant candidatesBrooke Chapman, Darren Wong, Marie Sinclair, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 30, 2013
Cyclosporine and tacrolimus have inhibitory effects on toll-like receptor signaling after liver transplantationJessica Howell, Rohit Sawhney, Adam Testro, et al.
World Journal of Gastroenterology|January 30, 2015
Characteristics of hepatocellular carcinoma in cirrhotic and non-cirrhotic non-alcoholic fatty liver diseaseChristopher Leung, Sern Wei Yeoh, Desmond Patrick, et al.
Journal of Hepatology|March 23, 2015
An autosomal dominant form of non-cirrhotic portal hypertensionAvik Majumdar, Martin B Delatycki, Peter Crowley, et al.
European Journal of Gastroenterology & Hepatology|July 3, 2023
Outcomes of patients with hepatorenal syndrome undergoing liver transplantation in the era of terlipressinRyma Terbah, Janet Cao, Darren Wong, et al.
Journal of Hepatology|June 15, 2010
Effects of a selective vasopressin V2 receptor antagonist, satavaptan, on ascites recurrence after paracentesis in patients with cirrhosisFlorence Wong, Pere Gines, Hugh Watson, et al.
Hepatology (Baltimore, Md.)|March 8, 2024
Reversing malnutrition and low muscle strength with targeted enteral feeding in patients awaiting liver transplant: A randomized controlled trialBrooke Chapman, Darren Wong, Marie Sinclair, et al.
Pageof 9

Showing results (31-40 of 85) with videos related to

Sort By:
Pageof 9
Journal of Gastroenterology and Hepatology|June 16, 2010
Efficacy and cost of a hepatocellular carcinoma screening program at an Australian teaching hospitalMary Y Y Qian, Rong Yuwei J, Peter Angus, et al.
World Journal of Hepatology|May 1, 2025
Rifaximin-α use is associated with improved muscle mass in patients with cirrhosisThomas Worland, Penelope Hey, Darren Wong, et al.
World Journal of Transplantation|August 18, 2022
Reduced upper limb lean mass on dual energy X-ray absorptiometry predicts adverse outcomes in male liver transplant recipientsPenelope Hey, Rudolf Hoermann, Paul Gow, et al.
Hepatology (Baltimore, Md.)|March 25, 2025
Reply: Targeted enteral feeding for malnutrition in liver transplant candidatesBrooke Chapman, Darren Wong, Marie Sinclair, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 30, 2013
Cyclosporine and tacrolimus have inhibitory effects on toll-like receptor signaling after liver transplantationJessica Howell, Rohit Sawhney, Adam Testro, et al.
World Journal of Gastroenterology|January 30, 2015
Characteristics of hepatocellular carcinoma in cirrhotic and non-cirrhotic non-alcoholic fatty liver diseaseChristopher Leung, Sern Wei Yeoh, Desmond Patrick, et al.
Journal of Hepatology|March 23, 2015
An autosomal dominant form of non-cirrhotic portal hypertensionAvik Majumdar, Martin B Delatycki, Peter Crowley, et al.
European Journal of Gastroenterology & Hepatology|July 3, 2023
Outcomes of patients with hepatorenal syndrome undergoing liver transplantation in the era of terlipressinRyma Terbah, Janet Cao, Darren Wong, et al.
Journal of Hepatology|June 15, 2010
Effects of a selective vasopressin V2 receptor antagonist, satavaptan, on ascites recurrence after paracentesis in patients with cirrhosisFlorence Wong, Pere Gines, Hugh Watson, et al.
Hepatology (Baltimore, Md.)|March 8, 2024
Reversing malnutrition and low muscle strength with targeted enteral feeding in patients awaiting liver transplant: A randomized controlled trialBrooke Chapman, Darren Wong, Marie Sinclair, et al.
Pageof 9